INTRODUCTION:
Tissue expander(TE) and implant infection is the most common cause of surgical readmission following breast reconstruction. The goals of this study are (1) to characterize a cohort of patients who were treated with IV antibiotics for suspected infection after prosthetic breast reconstruction, (2) to identify local microbiome and (3) elucidate an optimal antibiotic treatment protocol (4) to identify risk factors for explantation.
METHODS:
A retrospective review of a prospectively maintained database was performed to identify prosthetic breast reconstruction patients who were diagnosed with a suspected infection and underwent IV antibiotic treatment. Patient characteristics, surgical details, outcomes of the suspected infection, accompanying complications, treatment modalities and culture data were reviewed. Comparisons were made between patients whose implants were salvaged versus explanted.
RESULTS:
Fifty-nine patients with 67 tissue expanders/implants underwent IV antibiotic treatment with suspected infection during a twoyear period (2014) (2015) (2016) . Of the reconstructions, 44(66%) were tissue expanders and 23(34%) were implants. Mean follow-up was 14.3 months. The most common IV treatment protocol was a combination of Daptomycin and Zosyn. Cultures were obtained in 43 infectious episodes which revealed. S. epidermidis as the most commonly encountered pathogen followed by P. aeruginosa. A total of 34 devices (51%, 26 expanders and 8 implants) were explanted. Explantations were more common in patients with a history of chemotheraphy (p=0.02), hypertension (p=0.03) and those who underwent therapeutic mastectomy (p=0.03). A higher rate of explantation was observed among cases with coexisting complications, a history of radiation, and in patients with larger breasts, howerver this difference was not statistical significant.
CONCLUSION:
Chemotheraphy, hypertension and the therapeutic mastectomy were found to be independent risk factors for explantation due to postoperative infection following breast reconstruction. Prompt diagnosis of the implant infection with appropriate treatment, particularly in high risk patients is the key to avoid explantation. The combination therapy of Daptomycin and Zosyn has broad spectrum coverage and are found effective. Implant-based breast reconstruction is a well-established method for breast reconstruction. Although generally a safe procedure, when an infection arises in the implantpocket, it is often necessary for the patient to return to the operating room where the choices are to remove the implant and place the patient on antibiotics, or salvage the implant and give intravenous antibiotics. Recently, there has been a rise in the use of antibiotic-impregnated beads for the treatment of surgical site infections. These beads, made of biodegradable materials and loaded with antibiotics, are placed inside a surgical site prior to closure. As the beads break down, they release antibiotics locally over an extended period of time, thus allowing for implant salvage and eliminating the morbidity of systemic IV antibiotics. The goal of this study is to present a case series illustrating how the use of antibiotic beads prevents the need for IV antibiotics administered via a PICC line and, more importantly, increases the likelihood of implant salvage and infection recurrence.
The Use of Antibiotic Beads to

METHODS:
A single-center, retrospective analysis of all patients who underwent implant-based breast reconstruction at Mount Sinai Hospital was performed. All patients who developed an implant infection and then underwent capsulectomy with implant exchange and STIMULAN beads impregnated with antibiotics were included. Patient demographics, medical history, operative complications, and surgical outcomes were reviewed.
RESULTS:
Twelve patients were identified at Mount Sinai Hospital who fit the criteria. Ten patients had prior diagnoses of cancer in the affected breast. Comorbidities included hypertension, smoking, and immunocompromised status. Infections were noted anywhere from 5 days to 3 months post initial implant surgery. The surgical team was able to successfully salvage nine out of the twelve infected implants through the use of antibiotic bead therapy without the continued use of IV antibiotics.
CONCLUSION:
The use of antibiotic beads is promising for salvaging infected breast implants and reducing the need for IV antibiotics. The study team was able to salvage 75% of the implants. Of the three patients who had unsalvageable implants, one was infected with antibiotic resistant rhodococcus that was refractory to bead therapy and one was noncompliant with post-operative instructions. Overall, antibiotic beads allowed the surgical team to salvage the majority of implants without the need for PICC lines and associated morbidity. 
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